+ Plant=no_plant; PlantTreatment=None; Sample=soil; GrowthSubstrate=0.5X_MS_liquid; Collection=outgrowth_R2A_with_Tween_and_Cycloheximide; Time=21_days
| Pathway | #Steps | #Present | #Specific |
|---|
| UDP-α-D-galactose biosynthesis | 1 | 1 | 1 |
| UDP-N-acetyl-D-galactosamine biosynthesis I | 1 | 1 | 1 |
| L-glutamine degradation I | 1 | 1 | 1 |
| fatty acid β-oxidation III (unsaturated, odd number) | 1 | 1 | 1 |
| L-asparagine biosynthesis III (tRNA-dependent) | 4 | 4 | 3 |
| glutaminyl-tRNAgln biosynthesis via transamidation | 4 | 3 | 3 |
| benzoyl-CoA biosynthesis | 3 | 3 | 2 |
| L-glutamate biosynthesis I | 2 | 2 | 1 |
| UDP-α-D-galactofuranose biosynthesis | 2 | 1 | 1 |
| oleate β-oxidation (thioesterase-dependent, yeast) | 2 | 1 | 1 |
| oleate β-oxidation | 35 | 29 | 16 |
| fatty acid β-oxidation I (generic) | 7 | 5 | 3 |
| adipate degradation | 5 | 5 | 2 |
| adipate biosynthesis | 5 | 4 | 2 |
| fatty acid β-oxidation II (plant peroxisome) | 5 | 3 | 2 |
| glutaryl-CoA degradation | 5 | 3 | 2 |
| fatty acid β-oxidation IV (unsaturated, even number) | 5 | 3 | 2 |
| fatty acid β-oxidation V (unsaturated, odd number, di-isomerase-dependent) | 5 | 2 | 2 |
| pyruvate fermentation to hexanol (engineered) | 11 | 7 | 4 |
| (8E,10E)-dodeca-8,10-dienol biosynthesis | 11 | 6 | 4 |
| 2-methyl-branched fatty acid β-oxidation | 14 | 9 | 5 |
| ammonia assimilation cycle III | 3 | 3 | 1 |
| fatty acid salvage | 6 | 5 | 2 |
| valproate β-oxidation | 9 | 6 | 3 |
| L-isoleucine degradation I | 6 | 4 | 2 |
| pyruvate fermentation to butanol II (engineered) | 6 | 4 | 2 |
| 2-chloroacrylate degradation I | 3 | 2 | 1 |
| methyl ketone biosynthesis (engineered) | 6 | 3 | 2 |
| propanoate fermentation to 2-methylbutanoate | 6 | 3 | 2 |
| oleate β-oxidation (reductase-dependent, yeast) | 3 | 1 | 1 |
| D-galactose detoxification | 3 | 1 | 1 |
| benzoyl-CoA degradation I (aerobic) | 7 | 5 | 2 |
| Arg/N-end rule pathway (eukaryotic) | 14 | 8 | 4 |
| pyruvate fermentation to butanoate | 7 | 4 | 2 |
| fatty acid β-oxidation VI (mammalian peroxisome) | 7 | 3 | 2 |
| L-valine degradation I | 8 | 5 | 2 |
| pyruvate fermentation to butanol I | 8 | 3 | 2 |
| Salmonella enterica serotype O:8 O antigen biosynthesis | 8 | 2 | 2 |
| oleate β-oxidation (isomerase-dependent, yeast) | 4 | 1 | 1 |
| phenylacetate degradation I (aerobic) | 9 | 7 | 2 |
| superpathway of Clostridium acetobutylicum acidogenic fermentation | 9 | 6 | 2 |
| benzoate biosynthesis I (CoA-dependent, β-oxidative) | 9 | 5 | 2 |
| 4-hydroxybenzoate biosynthesis III (plants) | 5 | 4 | 1 |
| 4-chlorocatechol degradation | 5 | 4 | 1 |
| (R)- and (S)-3-hydroxybutanoate biosynthesis (engineered) | 5 | 3 | 1 |
| D-galactose degradation I (Leloir pathway) | 5 | 3 | 1 |
| 3-chlorocatechol degradation II (ortho) | 5 | 3 | 1 |
| L-glutamate degradation V (via hydroxyglutarate) | 10 | 5 | 2 |
| 3-phenylpropanoate degradation | 10 | 5 | 2 |
| 9-cis, 11-trans-octadecadienoyl-CoA degradation (isomerase-dependent, yeast) | 10 | 4 | 2 |
| 3-chlorocatechol degradation I (ortho) | 5 | 2 | 1 |
| benzoate biosynthesis III (CoA-dependent, non-β-oxidative) | 5 | 2 | 1 |
| Salmonella enterica serotype O:3,10 O antigen biosynthesis | 5 | 1 | 1 |
| superpathway of phenylethylamine degradation | 11 | 7 | 2 |
| superpathway of UDP-glucose-derived O-antigen building blocks biosynthesis | 6 | 4 | 1 |
| 6-gingerol analog biosynthesis (engineered) | 6 | 3 | 1 |
| L-glutamate degradation VII (to butanoate) | 12 | 5 | 2 |
| methylthiopropanoate degradation I (cleavage) | 6 | 2 | 1 |
| Salmonella enterica serotype O:2 O antigen biosynthesis | 6 | 1 | 1 |
| Salmonella enterica serotype O:4 O antigen biosynthesis (group B1) | 6 | 1 | 1 |
| Salmonella enterica serotype O:9,46 O antigen biosynthesis | 6 | 1 | 1 |
| Salmonella enterica serotype O:9 O antigen biosynthesis | 6 | 1 | 1 |
| Porphyromonas gingivalis O-LPS antigen biosynthesis | 6 | 1 | 1 |
| superpathway of Clostridium acetobutylicum solventogenic fermentation | 13 | 6 | 2 |
| L-glutamate and L-glutamine biosynthesis | 7 | 7 | 1 |
| superpathway of glyoxylate cycle and fatty acid degradation | 14 | 11 | 2 |
| UDP-N-acetyl-D-galactosamine biosynthesis II | 7 | 5 | 1 |
| 4,5-dichlorocatechol degradation | 7 | 5 | 1 |
| pyrimidine deoxyribonucleotides de novo biosynthesis II | 7 | 5 | 1 |
| stachyose degradation | 7 | 2 | 1 |
| Spodoptera littoralis pheromone biosynthesis | 22 | 4 | 3 |
| L-tryptophan degradation III (eukaryotic) | 15 | 6 | 2 |
| L-citrulline biosynthesis | 8 | 7 | 1 |
| glycerol degradation to butanol | 16 | 10 | 2 |
| 3,5-dichlorocatechol degradation | 8 | 5 | 1 |
| crotonate fermentation (to acetate and cyclohexane carboxylate) | 16 | 5 | 2 |
| 2-methylpropene degradation | 8 | 2 | 1 |
| superpathway of dimethylsulfoniopropanoate degradation | 8 | 2 | 1 |
| superpathway of Clostridium acetobutylicum acidogenic and solventogenic fermentation | 17 | 9 | 2 |
| benzoate fermentation (to acetate and cyclohexane carboxylate) | 17 | 6 | 2 |
| 3,4,6-trichlorocatechol degradation | 9 | 7 | 1 |
| 3-hydroxypropanoate/4-hydroxybutanate cycle | 18 | 10 | 2 |
| 1,4-dichlorobenzene degradation | 9 | 5 | 1 |
| UDP-sugars interconversion | 9 | 3 | 1 |
| toluene degradation VI (anaerobic) | 18 | 4 | 2 |
| teichuronic acid biosynthesis (B. subtilis 168) | 9 | 2 | 1 |
| Salmonella enterica serotype O:9,46,27 O antigen biosynthesis | 9 | 1 | 1 |
| methyl tert-butyl ether degradation | 10 | 3 | 1 |
| colanic acid building blocks biosynthesis | 11 | 11 | 1 |
| gallate degradation III (anaerobic) | 11 | 5 | 1 |
| superpathway of L-citrulline metabolism | 12 | 9 | 1 |
| 10-trans-heptadecenoyl-CoA degradation (reductase-dependent, yeast) | 12 | 2 | 1 |
| 10-cis-heptadecenoyl-CoA degradation (yeast) | 12 | 2 | 1 |
| androstenedione degradation I (aerobic) | 25 | 6 | 2 |
| platensimycin biosynthesis | 26 | 6 | 2 |
| (4Z,7Z,10Z,13Z,16Z)-docosapentaenoate biosynthesis (6-desaturase) | 13 | 2 | 1 |
| 1-butanol autotrophic biosynthesis (engineered) | 27 | 20 | 2 |
| androstenedione degradation II (anaerobic) | 27 | 4 | 2 |
| superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli) | 14 | 12 | 1 |
| superpathway of cholesterol degradation I (cholesterol oxidase) | 42 | 9 | 3 |
| superpathway of testosterone and androsterone degradation | 28 | 6 | 2 |
| docosahexaenoate biosynthesis III (6-desaturase, mammals) | 14 | 2 | 1 |
| succinoglycan biosynthesis | 14 | 1 | 1 |
| superpathway of cholesterol degradation II (cholesterol dehydrogenase) | 47 | 9 | 3 |
| cholesterol degradation to androstenedione I (cholesterol oxidase) | 17 | 3 | 1 |
| mycolyl-arabinogalactan-peptidoglycan complex biosynthesis | 18 | 1 | 1 |
| cholesterol degradation to androstenedione II (cholesterol dehydrogenase) | 22 | 3 | 1 |
| superpathway of cholesterol degradation III (oxidase) | 49 | 5 | 2 |
| photosynthetic 3-hydroxybutanoate biosynthesis (engineered) | 26 | 19 | 1 |
| superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis | 33 | 12 | 1 |